Coronavirus Vaccine Update From the CDC With Nancy Messonnier
Nancy E. Messonnier, MD is Director of the National Center for Immunization and Respiratory Diseases (NCIRD) at the @CDC and leads the CDC’s efforts on COVID-19 vaccination. She joins JAMA's Q&A series to discuss the agency's response to emerging coronavirus variants, the FDA advisory hearings on the new @jnj vaccine, and other agency activities and priorities related to COVID-19 control. Recorded February 26, 2021. Topics discussed in this interview: 0:00 Introduction 0:36 Variants 2:55 Rapidity of variant emergence 3:55 Staying the course with vaccination 5:52 Speed of vaccine deployment 7:05 Supply of vaccines 8:01 Struggles with distribution 9:20 Incentives for vaccination 12:05 Delaying the second dose 13:44 Vaccination with prior infection 14:52 Stratifying vaccines for different groups 18:09 Vaccination during pregnancy and breastfeeding 20:14 Immunocompromised individuals 22:38 Duration of immunity 23:50 Safety surveillance systems 26:46 Global approach to vaccination 28:28 AstraZeneca and Novavax 29:10 Surprises 30:59 Speed of vaccine development 32:21 Livestream interruption 35:17 Livestream continues 36:23 Booster doses 36:45 Which vaccine the Queen of England got 37:25 Equity and vaccine distribution • Earn Free CME credits by watching JAMA Livestreams and completing a brief questionnaire. Claim 0.5 credits for each video at https://ja.ma/covidqa • Coronavirus Resource page from the JAMA Network: https://ja.ma/covidyt • To watch all the #JAMALive Q&A's Visit: https://ja.ma/covidqaytpl • Don't forget to hit subscribe or click https://ja.ma/subscribe --------------------------------------------------------------------------------- For more from JAMA • https://www.jama.com • / jamajournal • / jama_current • / jamanetwork Follow the JAMA Network • https://www.jamanetwork.com • http://www.jamanetworkaudio.com • / jamanetwork • / jamanetwork • / jamanetwork • / jamanetwork ===================================================================== #JAMALive #Coronavirus #COVID19 #SARSCoV2 #Pandemic
